Latest Posts

Tag: Fidelity Management & Research Company

Editas Medicine raised $120M for advance genome editing

Editas Medicine, a leading genome editing company, raised $120 million in a highly oversubscribed Series B private financing. It is noted that Editas is translating the promise of CRISPR/Cas9 technology into a new class of transformative genomic medicines to treat a broad range of diseases by enabling precise and corrective molecular modifications to treat disease […]

Keep Reading
Huge Series C funding for Pax Labs

The amount of $46,7 million in Series C financing was raised by Pax Labs, led by Tao Capital and Sand Hill Angels, and the participation from Fidelity Management & Research Company, Sivia Capital, etc. The company, which develops the Pax botanical vaporizer, plans to use the new capital in order to expand internationally, since it […]

Keep Reading
Go to TOP